Complement-induced impairment of innate immunity during sepsis
- PMID: 12218141
- DOI: 10.4049/jimmunol.169.6.3223
Complement-induced impairment of innate immunity during sepsis
Abstract
This study defines the molecular basis for defects in innate immunity involving neutrophils during cecal ligation/puncture (CLP)-induced sepsis in rats. Blood neutrophils from CLP rats demonstrated defective phagocytosis and defective assembly of NADPH oxidase, the latter being due to the inability of p47(phox) to translocate from the cytosol to the cell membrane of neutrophils after cell stimulation by phorbol ester (PMA). The appearance of these defects was prevented by in vivo blockade of C5a in CLP rats. In vitro exposure of neutrophils to C5a led to reduced surface expression of C5aR and defective assembly of NADPH oxidase, as defined by failure in phosphorylation of p47(phox) and its translocation to the cell membrane, together with failure in phosphorylation of p42/p44 mitogen-activated protein kinases. These data identify a molecular basis for defective innate immunity involving neutrophils during sepsis.
Similar articles
-
The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils.J Immunol. 2000 Nov 1;165(9):5238-44. doi: 10.4049/jimmunol.165.9.5238. J Immunol. 2000. PMID: 11046057
-
Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.FASEB J. 2004 Feb;18(2):370-2. doi: 10.1096/fj.03-0708fje. Epub 2003 Dec 19. FASEB J. 2004. PMID: 14688199
-
Protection of innate immunity by C5aR antagonist in septic mice.FASEB J. 2002 Oct;16(12):1567-74. doi: 10.1096/fj.02-0209com. FASEB J. 2002. PMID: 12374779
-
The harmful role of c5a on innate immunity in sepsis.J Innate Immun. 2010;2(5):439-45. doi: 10.1159/000317194. Epub 2010 Jun 26. J Innate Immun. 2010. PMID: 20588003 Free PMC article. Review.
-
Role of C5a-C5aR interaction in sepsis.Shock. 2004 Jan;21(1):1-7. doi: 10.1097/01.shk.0000105502.75189.5e. Shock. 2004. PMID: 14676676 Review.
Cited by
-
Scientific and clinical challenges in sepsis.Curr Pharm Des. 2009;15(16):1918-35. doi: 10.2174/138161209788453248. Curr Pharm Des. 2009. PMID: 19519432 Free PMC article. Review.
-
Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L1003-13. doi: 10.1152/ajplung.00180.2011. Epub 2012 Mar 16. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22427530 Free PMC article.
-
Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis.Front Pharmacol. 2021 Dec 6;12:769190. doi: 10.3389/fphar.2021.769190. eCollection 2021. Front Pharmacol. 2021. PMID: 34938184 Free PMC article.
-
Sepsis, apoptosis and complement.Biochem Pharmacol. 2008 Dec 1;76(11):1383-8. doi: 10.1016/j.bcp.2008.09.017. Epub 2008 Sep 20. Biochem Pharmacol. 2008. PMID: 18848819 Free PMC article. Review.
-
CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction.PLoS One. 2015 Jul 15;10(7):e0132703. doi: 10.1371/journal.pone.0132703. eCollection 2015. PLoS One. 2015. PMID: 26176669 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous